市場調査レポート

商品コード

医薬品：市場規模と予測 (2021～2031年)、世界・地域シェア、動向、成長機会 - 分析範囲 (分子の種類別、適応症別、製品別、種類別、流通チャネル別、地域別)

Pharmaceuticals Market Size and Forecast 2021 - 2031, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Molecule Type, Indication, Product, Type, Distribution Channel, and Geography

出版日: 2025年04月04日
発行: The Insight Partners
ページ情報: 英文 383 Pages
納期: 即納可能

価格

PDF (Single User License)

USD 4,450 646,496円

レポートPDFを1名のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は一度のみ可能です。印刷したもののご利用はPDFのライセンス保持者に限定されます。

PDF (Site License)

USD 6,450 937,056円

レポートPDFを同一事業所（所在地）内のすべての方にご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷回数に制限はありません。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Enterprise License)

USD 8,450 1,227,616円

レポートPDFを企業内すべての方に使用頂けるライセンスです。PDF内のテキスト等のコピーは可能です。PDFの印刷回数に制限はありません。印刷したもののご利用はPDFのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=145.28円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

医薬品市場は、2024年の1兆7,577億8,000万米ドルから2031年には2兆8,403億米ドルに達すると予測され、2025年から2031年のCAGRは7.1%で成長すると推定されます。市場成長を促進する主な要因としては、世界の疾病負担の増加、革新的な治療に対する需要の増加、医薬品への世界のアクセスの拡大、新興市場の成長などが挙げられ、予測期間中に市場をさらに押し上げる可能性が高いです。しかし、規制による圧力や市場のシフトが市場の阻害要因となっています。

医薬品業界は、慢性的で深刻な健康状態に苦しむ人々の増加を主な要因として、毎年6%ずつ定期的に成長しています。糖尿病、肥満、がん、アルツハイマー病などの疾病の世界の負担は憂慮すべき速度で増加し続けており、医療の進歩の必要性を煽っています。現在、世界には1億7,100万人の糖尿病患者がおり、この数字は2030年までに倍増すると予想されています。肥満は14億人に影響し、2030年には33億人に達すると予測されています。さらに、1,800万人がアルツハイマー病を患っており、その数は2025年までに3,500万人に増加すると見られています。

こうした病気の増加に対処するため、製薬会社は革新的な治療法を生み出す研究開発に多額の投資を行っています。さらに、イタリアだけでも製薬会社によって年間7億ユーロが臨床試験に投資されており、医療機器会社を含めると10億ユーロに上ります。さらに、米国国立衛生研究所、米国FDA、製薬会社10社、非営利団体5団体が協力して、希少疾患に苦しむ3,000万人のアメリカ人のために遺伝子治療開発を加速させるなど、官民パートナーシップ（PPP）の役割が高まっていることも、これを後押ししています。

COVID-19の影響は医薬品市場の拡大にも大きく影響し、2020年から2027年までの累積市場成長率は純額で5,000億米ドルに上ると推定されます。全地域で第一波のワクチン接種率を上回ったもの、ブースターの利用率には依然としてばらつきがあり、パンデミックの今後の推移に不透明感をもたらしています。革新的医薬品に対する需要は引き続き急増し、特にがん領域では2027年までに現在のほぼ2倍となる3,700億米ドルに達すると予測されます。さらに、スペシャリティ医薬品は2027年までに全世界の支出額の43％を占め、新興国市場では総支出額の56％を占めると予想されます。画期的な細胞治療や遺伝子治療を含むバイオ医薬品は、2027年までに世界の支出の35％を占めるようになり、先端バイオ治療薬へのシフトを示します。

競合企業別分析は、製品ポートフォリオ（製品満足度、製品の特徴、入手可能性）、最近の市場動向（合併・買収、新製品の上市・強化、投資・資金調達、受賞・合意・提携・パートナーシップ、認知度、事業拡大）、地域的プレゼンスに基づいて医薬品市場を評価・分類し、より良い意思決定と競合情勢の理解を支援します。本レポートでは、世界の医薬品市場における主要ベンダーの最近の重要な動向とイノベーションについて深く調査しています。主な市場プレイヤーは、ジョンソン・エンド・ジョンソン、ファイザー、メルク・アンド・カンパニー、イーライリリー・アンド・カンパニー、ブリストル・マイヤーズスクイブ、エステーブ、UCB SA、テバ・ファーマシューティカル・インダストリーズ・リミテッド、ヒクマ・ファーマシューティカルズ・ピーエルシー、ヴィアトリス・インク、アストラゼネカ・ピーエルシー、サノフィSA、GSK PIc、エフ・ホフマン・ラ・ロシュ・リミテッド、ノバルティスAG、アッヴィ・インクです。

医薬品市場は分子タイプに基づき、低分子製品、生物学的製剤、バイオシミラー製品に区分されます。2024年には、低分子製品が市場で最大のシェアを占める。適応症に基づくと、医薬品市場は代謝性疾患、がん、免疫学、呼吸器疾患、心血管疾患、神経疾患、希少疾患、その他に区分されます。2024年には、がん分野が最大のシェアを占めています。製品別では、医薬品市場はブランド医薬品、ジェネリック医薬品に区分されます。2024年には、ブランド品セグメントが最大のシェアを占めています。医薬品市場は流通チャネルに基づき、病院薬局、小売薬局、オンライン薬局に区分されます。2024年には、病院薬局セグメントが最大のシェアを占めています。

医薬品市場で事業を展開する企業は、さまざまな有機的・無機的戦略を採用しています。有機的戦略には主に、製品発売や製品承認が含まれます。市場で見られる無機的成長戦略には、買収、提携、パートナーシップなどがあります。これらの成長戦略により、市場参入企業は事業を拡大し、地理的プレゼンスを高めるとともに、市場全体の成長に貢献することができます。さらに、買収や提携などの戦略は、顧客基盤を強化し、製品ポートフォリオを拡大するのに役立っています。医薬品市場における主要企業の重要な発展の一部を以下に示します。

2025年3月、ジョンソン・エンド・ジョンソン傘下のヤンセン・シラグ・インターナショナルNVは、欧州医薬品庁のヒト用医薬品委員会（CHMP）がダルザレックス（一般名：ダラツムマブ）皮下注（SC）製剤の適応拡大承認を勧告したと発表しました。今回の勧告は、新規診断多発性骨髄腫（NDMM）の成人患者に対するボルテゾミブ、レナリドミド、デキサメタゾンとの併用療法（ダラツムマブ-VRd）に対するものです。

医薬品市場：主な市場力学
市場促進要因
- 世界の疾病負担の増大と革新的治療への需要の高まり
- 世界の医薬品アクセスの拡大と新興市場の成長
市場抑制要因
- 規制による圧力と市場の変化
市場機会
- イノベーション、AI、市場拡大の活用
今後の動向
- 域内のパワーシフト、サプライチェーンの多様化、規制の進化
促進要因と抑制要因の影響

第6章医薬品市場：世界市場の分析

医薬品市場の収益 (2021～2031年)
医薬品市場の予測・分析

第7章医薬品市場の分析：分子の種類別

低分子製品
生物学的製剤・バイオシミラー製剤

第8章医薬品市場の分析：適応症別

代謝性疾患
がん
免疫学
呼吸器疾患
心血管疾患
神経疾患
希少疾患
その他

第9章医薬品市場の分析：製品別

ブランド
ジェネリック医薬品

第10章医薬品市場の分析：種類別

処方薬
市販薬 (OTC)

第11章医薬品市場の分析：流通チャネル別

病院薬局
小売薬局
オンライン薬局

第12章医薬品市場：地域別分析

北米
- 米国
- カナダ
- メキシコ
欧州
- 英国
- ドイツ
- フランス
- イタリア
- スペイン
- スイス
- その他欧州
アジア太平洋
- 中国
- 日本
- インド
- オーストラリア
- 韓国
- その他アジア太平洋
中東・アフリカ
- 南アフリカ
- サウジアラビア
- アラブ首長国連邦
- その他中東とアフリカ
中南米
- ブラジル
- アルゼンチン
- その他中南米

第13章競合情勢

企業シェア分析

第14章業界情勢

事業拡大
新製品開発
企業合併・買収 (M&A)
パートナーシップ
その他の事業戦略

第15章企業プロファイル

Johnson & Johnson
Pfizer Inc
Merck & Co Inc
Eli Lilly and Co
Bristol-Myers Squibb Co
ESTEVE
UCB SA
Teva Pharmaceutical Industries Ltd
Hikma Pharmaceuticals Plc
Viatris Inc
AstraZeneca Plc
Sanofi SA
GSK Plc
F. Hoffmann-La Roche Ltd
Novartis AG
AbbVie Inc

第16章付録

図表

List Of Tables

Table 1. Pharmaceutical Market Segmentation
Table 2. Pharmaceutical Market - Revenue, 2021- 2024 (US$ Billion)
Table 3. Pharmaceutical Market - Revenue, 2025- 2031 (US$ Billion)
Table 4. Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Molecule Type
Table 5. Pharmaceutical Market - Revenue, 2025 - 2031(US$ Billion) - by Molecule Type
Table 6. Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Indication
Table 7. Pharmaceutical Market - Revenue, 2025 - 2031(US$ Billion) - by Indication
Table 8. Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Product
Table 9. Pharmaceutical Market - Revenue, 2025 - 2031(US$ Billion) - by Product
Table 10. Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Type
Table 11. Pharmaceutical Market - Revenue, 2025 - 2031(US$ Billion) - by Type
Table 12. Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Distribution Channel
Table 13. Pharmaceutical Market - Revenue, 2025 - 2031(US$ Billion) - by Distribution Channel
Table 14. North America: Pharmaceutical Market - Revenue, 2021 - 2024 (US$ Billion) - by Molecule Type
Table 15. North America: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Molecule Type
Table 16. North America: Pharmaceutical Market - Revenue, 2021 - 2024 (US$ Billion) - by Indication
Table 17. North America: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Indication
Table 18. North America: Pharmaceutical Market - Revenue, 2021 - 2024 (US$ Billion) - by Product
Table 19. North America: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Product
Table 20. North America: Pharmaceutical Market - Revenue, 2021 - 2024 (US$ Billion) - by Type
Table 21. North America: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Type
Table 22. North America: Pharmaceutical Market - Revenue, 2021 - 2024 (US$ Billion) - by Distribution Channel
Table 23. North America: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Distribution Channel
Table 24. North America: Pharmaceutical Market - Revenue, 2021 - 2024 (US$ Billion) - by Country
Table 25. North America: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Country
Table 26. United States: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Molecule Type
Table 27. United States: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Molecule Type
Table 28. United States: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Indication
Table 29. United States: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Indication
Table 30. United States: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Product
Table 31. United States: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Product
Table 32. United States: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Type
Table 33. United States: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Type
Table 34. United States: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Distribution Channel
Table 35. United States: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Distribution Channel
Table 36. Canada: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Molecule Type
Table 37. Canada: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Molecule Type
Table 38. Canada: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Indication
Table 39. Canada: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Indication
Table 40. Canada: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Product
Table 41. Canada: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Product
Table 42. Canada: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Type
Table 43. Canada: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Type
Table 44. Canada: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Distribution Channel
Table 45. Canada: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Distribution Channel
Table 46. Mexico: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Molecule Type
Table 47. Mexico: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Molecule Type
Table 48. Mexico: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Indication
Table 49. Mexico: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Indication
Table 50. Mexico: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Product
Table 51. Mexico: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Product
Table 52. Mexico: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Type
Table 53. Mexico: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Type
Table 54. Mexico: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Distribution Channel
Table 55. Mexico: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Distribution Channel
Table 56. Europe: Pharmaceutical Market - Revenue, 2021 - 2024 (US$ Billion) - by Molecule Type
Table 57. Europe: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Molecule Type
Table 58. Europe: Pharmaceutical Market - Revenue, 2021 - 2024 (US$ Billion) - by Indication
Table 59. Europe: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Indication
Table 60. Europe: Pharmaceutical Market - Revenue, 2021 - 2024 (US$ Billion) - by Product
Table 61. Europe: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Product
Table 62. Europe: Pharmaceutical Market - Revenue, 2021 - 2024 (US$ Billion) - by Type
Table 63. Europe: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Type
Table 64. Europe: Pharmaceutical Market - Revenue, 2021 - 2024 (US$ Billion) - by Distribution Channel
Table 65. Europe: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Distribution Channel
Table 66. Europe: Pharmaceutical Market - Revenue, 2021 - 2024 (US$ Billion) - by Country
Table 67. Europe: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Country
Table 68. United Kingdom: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Molecule Type
Table 69. United Kingdom: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Molecule Type
Table 70. United Kingdom: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Indication
Table 71. United Kingdom: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Indication
Table 72. United Kingdom: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Product
Table 73. United Kingdom: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Product
Table 74. United Kingdom: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Type
Table 75. United Kingdom: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Type
Table 76. United Kingdom: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Distribution Channel
Table 77. United Kingdom: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Distribution Channel
Table 78. Germany: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Molecule Type
Table 79. Germany: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Molecule Type
Table 80. Germany: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Indication
Table 81. Germany: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Indication
Table 82. Germany: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Product
Table 83. Germany: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Product
Table 84. Germany: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Type
Table 85. Germany: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Type
Table 86. Germany: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Distribution Channel
Table 87. Germany: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Distribution Channel
Table 88. France: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Molecule Type
Table 89. France: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Molecule Type
Table 90. France: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Indication
Table 91. France: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Indication
Table 92. France: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Product
Table 93. France: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Product
Table 94. France: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Type
Table 95. France: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Type
Table 96. France: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Distribution Channel
Table 97. France: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Distribution Channel
Table 98. Italy: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Molecule Type
Table 99. Italy: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Molecule Type
Table 100. Italy: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Indication
Table 101. Italy: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Indication
Table 102. Italy: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Product
Table 103. Italy: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Product
Table 104. Italy: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Type
Table 105. Italy: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Type
Table 106. Italy: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Distribution Channel
Table 107. Italy: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Distribution Channel
Table 108. Spain: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Molecule Type
Table 109. Spain: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Molecule Type
Table 110. Spain: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Indication
Table 111. Spain: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Indication
Table 112. Spain: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Product
Table 113. Spain: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Product
Table 114. Spain: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Type
Table 115. Spain: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Type
Table 116. Spain: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Distribution Channel
Table 117. Spain: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Distribution Channel
Table 118. Switzerland: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Molecule Type
Table 119. Switzerland: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Molecule Type
Table 120. Switzerland: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Indication
Table 121. Switzerland: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Indication
Table 122. Switzerland: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Product
Table 123. Switzerland: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Product
Table 124. Switzerland: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Type
Table 125. Switzerland: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Type
Table 126. Switzerland: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Distribution Channel
Table 127. Switzerland: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Distribution Channel
Table 128. Rest of Europe: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Molecule Type
Table 129. Rest of Europe: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Molecule Type
Table 130. Rest of Europe: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Indication
Table 131. Rest of Europe: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Indication
Table 132. Rest of Europe: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Product
Table 133. Rest of Europe: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Product
Table 134. Rest of Europe: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Type
Table 135. Rest of Europe: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Type
Table 136. Rest of Europe: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Distribution Channel
Table 137. Rest of Europe: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Distribution Channel
Table 138. Asia Pacific: Pharmaceutical Market - Revenue, 2021 - 2024 (US$ Billion) - by Molecule Type
Table 139. Asia Pacific: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Molecule Type
Table 140. Asia Pacific: Pharmaceutical Market - Revenue, 2021 - 2024 (US$ Billion) - by Indication
Table 141. Asia Pacific: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Indication
Table 142. Asia Pacific: Pharmaceutical Market - Revenue, 2021 - 2024 (US$ Billion) - by Product
Table 143. Asia Pacific: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Product
Table 144. Asia Pacific: Pharmaceutical Market - Revenue, 2021 - 2024 (US$ Billion) - by Type
Table 145. Asia Pacific: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Type
Table 146. Asia Pacific: Pharmaceutical Market - Revenue, 2021 - 2024 (US$ Billion) - by Distribution Channel
Table 147. Asia Pacific: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Distribution Channel
Table 148. Asia Pacific: Pharmaceutical Market - Revenue, 2021 - 2024 (US$ Billion) - by Country
Table 149. Asia Pacific: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Country
Table 150. China: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Molecule Type
Table 151. China: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Molecule Type
Table 152. China: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Indication
Table 153. China: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Indication
Table 154. China: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Product
Table 155. China: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Product
Table 156. China: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Type
Table 157. China: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Type
Table 158. China: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Distribution Channel
Table 159. China: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Distribution Channel
Table 160. Japan: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Molecule Type
Table 161. Japan: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Molecule Type
Table 162. Japan: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Indication
Table 163. Japan: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Indication
Table 164. Japan: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Product
Table 165. Japan: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Product
Table 166. Japan: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Type
Table 167. Japan: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Type
Table 168. Japan: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Distribution Channel
Table 169. Japan: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Distribution Channel
Table 170. India: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Molecule Type
Table 171. India: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Molecule Type
Table 172. India: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Indication
Table 173. India: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Indication
Table 174. India: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Product
Table 175. India: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Product
Table 176. India: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Type
Table 177. India: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Type
Table 178. India: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Distribution Channel
Table 179. India: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Distribution Channel
Table 180. Australia: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Molecule Type
Table 181. Australia: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Molecule Type
Table 182. Australia: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Indication
Table 183. Australia: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Indication
Table 184. Australia: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Product
Table 185. Australia: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Product
Table 186. Australia: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Type
Table 187. Australia: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Type
Table 188. Australia: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Distribution Channel
Table 189. Australia: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Distribution Channel
Table 190. South Korea: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Molecule Type
Table 191. South Korea: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Molecule Type
Table 192. South Korea: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Indication
Table 193. South Korea: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Indication
Table 194. South Korea: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Product
Table 195. South Korea: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Product
Table 196. South Korea: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Type
Table 197. South Korea: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Type
Table 198. South Korea: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Distribution Channel
Table 199. South Korea: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Distribution Channel
Table 200. Rest of APAC: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Molecule Type
Table 201. Rest of APAC: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Molecule Type
Table 202. Rest of APAC: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Indication
Table 203. Rest of APAC: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Indication
Table 204. Rest of APAC: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Product
Table 205. Rest of APAC: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Product
Table 206. Rest of APAC: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Type
Table 207. Rest of APAC: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Type
Table 208. Rest of APAC: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Distribution Channel
Table 209. Rest of APAC: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Distribution Channel
Table 210. Middle East and Africa: Pharmaceutical Market - Revenue, 2021 - 2024 (US$ Billion) - by Molecule Type
Table 211. Middle East and Africa: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Molecule Type
Table 212. Middle East and Africa: Pharmaceutical Market - Revenue, 2021 - 2024 (US$ Billion) - by Indication
Table 213. Middle East and Africa: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Indication
Table 214. Middle East and Africa: Pharmaceutical Market - Revenue, 2021 - 2024 (US$ Billion) - by Product
Table 215. Middle East and Africa: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Product
Table 216. Middle East and Africa: Pharmaceutical Market - Revenue, 2021 - 2024 (US$ Billion) - by Type
Table 217. Middle East and Africa: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Type
Table 218. Middle East and Africa: Pharmaceutical Market - Revenue, 2021 - 2024 (US$ Billion) - by Distribution Channel
Table 219. Middle East and Africa: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Distribution Channel
Table 220. Middle East and Africa: Pharmaceutical Market - Revenue, 2021 - 2024 (US$ Billion) - by Country
Table 221. Middle East and Africa: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Country
Table 222. South Africa: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Molecule Type
Table 223. South Africa: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Molecule Type
Table 224. South Africa: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Indication
Table 225. South Africa: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Indication
Table 226. South Africa: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Product
Table 227. South Africa: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Product
Table 228. South Africa: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Type
Table 229. South Africa: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Type
Table 230. South Africa: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Distribution Channel
Table 231. South Africa: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Distribution Channel
Table 232. Saudi Arabia: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Molecule Type
Table 233. Saudi Arabia: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Molecule Type
Table 234. Saudi Arabia: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Indication
Table 235. Saudi Arabia: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Indication
Table 236. Saudi Arabia: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Product
Table 237. Saudi Arabia: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Product
Table 238. Saudi Arabia: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Type
Table 239. Saudi Arabia: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Type
Table 240. Saudi Arabia: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Distribution Channel
Table 241. Saudi Arabia: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Distribution Channel
Table 242. United Arab Emirates: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Molecule Type
Table 243. United Arab Emirates: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Molecule Type
Table 244. United Arab Emirates: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Indication
Table 245. United Arab Emirates: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Indication
Table 246. United Arab Emirates: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Product
Table 247. United Arab Emirates: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Product
Table 248. United Arab Emirates: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Type
Table 249. United Arab Emirates: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Type
Table 250. United Arab Emirates: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Distribution Channel
Table 251. United Arab Emirates: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Distribution Channel
Table 252. Rest of Middle East and Africa: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Molecule Type
Table 253. Rest of Middle East and Africa: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Molecule Type
Table 254. Rest of Middle East and Africa: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Indication
Table 255. Rest of Middle East and Africa: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Indication
Table 256. Rest of Middle East and Africa: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Product
Table 257. Rest of Middle East and Africa: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Product
Table 258. Rest of Middle East and Africa: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Type
Table 259. Rest of Middle East and Africa: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Type
Table 260. Rest of Middle East and Africa: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Distribution Channel
Table 261. Rest of Middle East and Africa: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Distribution Channel
Table 262. South and Central America: Pharmaceutical Market - Revenue, 2021 - 2024 (US$ Billion) - by Molecule Type
Table 263. South and Central America: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Molecule Type
Table 264. South and Central America: Pharmaceutical Market - Revenue, 2021 - 2024 (US$ Billion) - by Indication
Table 265. South and Central America: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Indication
Table 266. South and Central America: Pharmaceutical Market - Revenue, 2021 - 2024 (US$ Billion) - by Product
Table 267. South and Central America: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Product
Table 268. South and Central America: Pharmaceutical Market - Revenue, 2021 - 2024 (US$ Billion) - by Type
Table 269. South and Central America: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Type
Table 270. South and Central America: Pharmaceutical Market - Revenue, 2021 - 2024 (US$ Billion) - by Distribution Channel
Table 271. South and Central America: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Distribution Channel
Table 272. South and Central America: Pharmaceutical Market - Revenue, 2021 - 2024 (US$ Billion) - by Country
Table 273. South and Central America: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Country
Table 274. Brazil: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Molecule Type
Table 275. Brazil: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Molecule Type
Table 276. Brazil: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Indication
Table 277. Brazil: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Indication
Table 278. Brazil: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Product
Table 279. Brazil: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Product
Table 280. Brazil: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Type
Table 281. Brazil: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Type
Table 282. Brazil: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Distribution Channel
Table 283. Brazil: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Distribution Channel
Table 284. Argentina: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Molecule Type
Table 285. Argentina: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Molecule Type
Table 286. Argentina: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Indication
Table 287. Argentina: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Indication
Table 288. Argentina: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Product
Table 289. Argentina: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Product
Table 290. Argentina: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Type
Table 291. Argentina: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Type
Table 292. Argentina: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Distribution Channel
Table 293. Argentina: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Distribution Channel
Table 294. Rest of South and Central America: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Molecule Type
Table 295. Rest of South and Central America: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Molecule Type
Table 296. Rest of South and Central America: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Indication
Table 297. Rest of South and Central America: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Indication
Table 298. Rest of South and Central America: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Product
Table 299. Rest of South and Central America: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Product
Table 300. Rest of South and Central America: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Type
Table 301. Rest of South and Central America: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Type
Table 302. Rest of South and Central America: Pharmaceutical Market - Revenue, 2021 -2024(US$ Billion) - by Distribution Channel
Table 303. Rest of South and Central America: Pharmaceutical Market - Revenue, 2025 - 2031 (US$ Billion) - by Distribution Channel
Table 304. Company Market Share Analysis
Table 305. Glossary of Terms, Pharmaceutical Market

List Of Figures

Figure 1. Pharmaceutical Market Segmentation, by Geography
Figure 2. PEST Analysis
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Pharmaceutical Market Revenue (US$ Billion), 2021-2031
Figure 5. Pharmaceutical Market Share (%) - by Molecule Type (2024 and 2031)
Figure 6. Small Molecule: Pharmaceutical Market - Revenue and Forecast to 2031 (US$ Billion)
Figure 7. Biological and Biosimilar Products: Pharmaceutical Market - Revenue and Forecast to 2031 (US$ Billion)
Figure 8. Pharmaceutical Market Share (%) - by Indication (2024 and 2031)
Figure 9. Metabolic Diseases: Pharmaceutical Market - Revenue and Forecast to 2031 (US$ Billion)
Figure 10. Cancer: Pharmaceutical Market - Revenue and Forecast to 2031 (US$ Billion)
Figure 11. Immunology: Pharmaceutical Market - Revenue and Forecast to 2031 (US$ Billion)
Figure 12. Respiratory Disorder: Pharmaceutical Market - Revenue and Forecast to 2031 (US$ Billion)
Figure 13. Cardiovascular Disorder: Pharmaceutical Market - Revenue and Forecast to 2031 (US$ Billion)
Figure 14. Neurology Disorder: Pharmaceutical Market - Revenue and Forecast to 2031 (US$ Billion)
Figure 15. Rare Disease: Pharmaceutical Market - Revenue and Forecast to 2031 (US$ Billion)
Figure 16. Others: Pharmaceutical Market - Revenue and Forecast to 2031 (US$ Billion)
Figure 17. Pharmaceutical Market Share (%) - by Product (2024 and 2031)
Figure 18. Branded: Pharmaceutical Market - Revenue and Forecast to 2031 (US$ Billion)
Figure 19. Generic: Pharmaceutical Market - Revenue and Forecast to 2031 (US$ Billion)
Figure 20. Pharmaceutical Market Share (%) - by Type (2024 and 2031)
Figure 21. Prescription: Pharmaceutical Market - Revenue and Forecast to 2031 (US$ Billion)
Figure 22. OTC Drugs: Pharmaceutical Market - Revenue and Forecast to 2031 (US$ Billion)
Figure 23. Pharmaceutical Market Share (%) - by Distribution Channel (2024 and 2031)
Figure 24. Hospital Pharmacies: Pharmaceutical Market - Revenue and Forecast to 2031 (US$ Billion)
Figure 25. Retail Pharmacies: Pharmaceutical Market - Revenue and Forecast to 2031 (US$ Billion)
Figure 26. Online Pharmacies: Pharmaceutical Market - Revenue and Forecast to 2031 (US$ Billion)
Figure 27. Pharmaceutical Market Breakdown by Region, 2024 and 2031 (%)
Figure 28. North America: Pharmaceutical Market - Revenue, 2021 - 2031 (US$ Billion)
Figure 29. North America: Pharmaceutical Market Breakdown, by Molecule Type (2024 and 2031)
Figure 30. North America: Pharmaceutical Market Breakdown, by Indication (2024 and 2031)
Figure 31. North America: Pharmaceutical Market Breakdown, by Product (2024 and 2031)
Figure 32. North America: Pharmaceutical Market Breakdown, by Type (2024 and 2031)
Figure 33. North America: Pharmaceutical Market Breakdown, by Distribution Channel (2024 and 2031)
Figure 34. North America: Pharmaceutical Market Breakdown, by Key Countries, 2024 and 2031 (%)
Figure 35. United States: Pharmaceutical Market - Revenue, 2021 - 2031 (US$ Billion)
Figure 36. Canada: Pharmaceutical Market - Revenue, 2021 - 2031 (US$ Billion)
Figure 37. Mexico: Pharmaceutical Market - Revenue, 2021 - 2031 (US$ Billion)
Figure 38. Europe: Pharmaceutical Market - Revenue, 2021 - 2031 (US$ Billion)
Figure 39. Europe: Pharmaceutical Market Breakdown, by Molecule Type (2024 and 2031)
Figure 40. Europe: Pharmaceutical Market Breakdown, by Indication (2024 and 2031)
Figure 41. Europe: Pharmaceutical Market Breakdown, by Product (2024 and 2031)
Figure 42. Europe: Pharmaceutical Market Breakdown, by Type (2024 and 2031)
Figure 43. Europe: Pharmaceutical Market Breakdown, by Distribution Channel (2024 and 2031)
Figure 44. Europe: Pharmaceutical Market Breakdown, by Key Countries, 2024 and 2031 (%)
Figure 45. United Kingdom: Pharmaceutical Market - Revenue, 2021 - 2031 (US$ Billion)
Figure 46. Germany: Pharmaceutical Market - Revenue, 2021 - 2031 (US$ Billion)
Figure 47. France: Pharmaceutical Market - Revenue, 2021 - 2031 (US$ Billion)
Figure 48. Italy: Pharmaceutical Market - Revenue, 2021 - 2031 (US$ Billion)
Figure 49. Spain: Pharmaceutical Market - Revenue, 2021 - 2031 (US$ Billion)
Figure 50. Switzerland: Pharmaceutical Market - Revenue, 2021 - 2031 (US$ Billion)
Figure 51. Rest of Europe: Pharmaceutical Market - Revenue, 2021 - 2031 (US$ Billion)
Figure 52. Asia Pacific: Pharmaceutical Market - Revenue, 2021 - 2031 (US$ Billion)
Figure 53. Asia Pacific: Pharmaceutical Market Breakdown, by Molecule Type (2024 and 2031)
Figure 54. Asia Pacific: Pharmaceutical Market Breakdown, by Indication (2024 and 2031)
Figure 55. Asia Pacific: Pharmaceutical Market Breakdown, by Product (2024 and 2031)
Figure 56. Asia Pacific: Pharmaceutical Market Breakdown, by Type (2024 and 2031)
Figure 57. Asia Pacific: Pharmaceutical Market Breakdown, by Distribution Channel (2024 and 2031)
Figure 58. Asia Pacific: Pharmaceutical Market Breakdown, by Key Countries, 2024 and 2031 (%)
Figure 59. China: Pharmaceutical Market - Revenue, 2021 - 2031 (US$ Billion)
Figure 60. Japan: Pharmaceutical Market - Revenue, 2021 - 2031 (US$ Billion)
Figure 61. India: Pharmaceutical Market - Revenue, 2021 - 2031 (US$ Billion)
Figure 62. Australia: Pharmaceutical Market - Revenue, 2021 - 2031 (US$ Billion)
Figure 63. South Korea: Pharmaceutical Market - Revenue, 2021 - 2031 (US$ Billion)
Figure 64. Rest of APAC: Pharmaceutical Market - Revenue, 2021 - 2031 (US$ Billion)
Figure 65. Middle East and Africa: Pharmaceutical Market - Revenue, 2021 - 2031 (US$ Billion)
Figure 66. Middle East and Africa: Pharmaceutical Market Breakdown, by Molecule Type (2024 and 2031)
Figure 67. Middle East and Africa: Pharmaceutical Market Breakdown, by Indication (2024 and 2031)
Figure 68. Middle East and Africa: Pharmaceutical Market Breakdown, by Product (2024 and 2031)
Figure 69. Middle East and Africa: Pharmaceutical Market Breakdown, by Type (2024 and 2031)
Figure 70. Middle East and Africa: Pharmaceutical Market Breakdown, by Distribution Channel (2024 and 2031)
Figure 71. Middle East and Africa: Pharmaceutical Market Breakdown, by Key Countries, 2024 and 2031 (%)
Figure 72. South Africa: Pharmaceutical Market - Revenue, 2021 - 2031 (US$ Billion)
Figure 73. Saudi Arabia: Pharmaceutical Market - Revenue, 2021 - 2031 (US$ Billion)
Figure 74. United Arab Emirates: Pharmaceutical Market - Revenue, 2021 - 2031 (US$ Billion)
Figure 75. Rest of Middle East and Africa: Pharmaceutical Market - Revenue, 2021 - 2031 (US$ Billion)
Figure 76. South and Central America: Pharmaceutical Market - Revenue, 2021 - 2031 (US$ Billion)
Figure 77. South and Central America: Pharmaceutical Market Breakdown, by Molecule Type (2024 and 2031)
Figure 78. South and Central America: Pharmaceutical Market Breakdown, by Indication (2024 and 2031)
Figure 79. South and Central America: Pharmaceutical Market Breakdown, by Product (2024 and 2031)
Figure 80. South and Central America: Pharmaceutical Market Breakdown, by Type (2024 and 2031)
Figure 81. South and Central America: Pharmaceutical Market Breakdown, by Distribution Channel (2024 and 2031)
Figure 82. South and Central America: Pharmaceutical Market Breakdown, by Key Countries, 2024 and 2031 (%)
Figure 83. Brazil: Pharmaceutical Market - Revenue, 2021 - 2031 (US$ Billion)
Figure 84. Argentina: Pharmaceutical Market - Revenue, 2021 - 2031 (US$ Billion)
Figure 85. Rest of South and Central America: Pharmaceutical Market - Revenue, 2021 - 2031 (US$ Billion)

Product Code: TIPRE00029839

The pharmaceuticals market is expected to reach US$ 2,840.30 billion by 2031 from US$ 1,757.78 billion in 2024; the market is estimated to grow at a CAGR of 7.1% during 2025-2031. Major factors driving the market growth include rising global disease burden and increasing demand for innovative treatments and expanding global access to medicines and growing emerging markets further are likely to boost the market during the forecast period. However, regulatory pressures and market shifts among the market deterrents.

The pharmaceutical industry regularly grows by 6% every year, primarily due to the increasing number of people suffering from chronic and severe health conditions. The global burden of diseases such as diabetes, obesity, cancer, and Alzheimer's continues to rise at an alarming rate, fueling the need for medical advancements. There are currently 171 million diabetics worldwide, and this figure is expected to double by 2030. Obesity affects 1.4 billion people, and projections estimate that this number will reach 3.3 billion by 2030. Furthermore, 18 million people suffer from Alzheimer's, and the number is likely to increase to 35 million by 2025.

To address these growing illnesses, pharmaceutical companies are investing heavily in research and development research and development to create innovative treatments. Additionally, € 700 million is invested annually in clinical trials by pharma companies in Italy alone, rising to € 1 billion if medical device companies are included. This is further supported by the increasing role of public-private partnerships (PPPs), such as the collaboration between the National Institutes of Health, the U.S. FDA, 10 pharmaceutical companies, and five non-profit organizations to accelerate gene therapy development for 30 million Americans suffering from rare diseases.

The impact of COVID-19 has also significantly shaped pharmaceutical market expansion, adding an estimated US$ 500 billion in net cumulative market growth from 2020 through 2027. While all regions have exceeded first-wave vaccination rates, booster utilization remains inconsistent, creating uncertainties about the future course of the pandemic. The demand for innovative drugs will continue to surge, particularly in oncology, where spending is projected to reach US$ 370 billion by 2027-almost double the current level. Moreover, specialty medicines will represent 43% of global spending by 2027 and 56% of total spending in developed markets. Biotech medicines, including breakthrough cell and gene therapies, will account for 35% of global spending by 2027, marking a shift toward advanced biotherapeutics.

The comparative company analysis evaluates and categorizes the pharmaceuticals market based on product portfolio (product satisfaction, product features, and availability), recent market developments (merger & acquisition, new product launch & enhancement, investment & funding, award, agreement, collaboration, & partnership, recognition, and expansion), and geographic presence that aids better decision-making and understanding of the competitive landscape. The report profoundly explores the recent significant developments and innovations by the leading vendors in the global pharmaceuticals market. The key market players are Johnson & Johnson, Pfizer Inc, Merck & Co Inc, Eli Lilly and Co, Bristol-Myers Squibb Co, ESTEVE, UCB SA, Teva Pharmaceutical Industries Ltd, Hikma Pharmaceuticals Plc, Viatris Inc, AstraZeneca Plc, Sanofi SA, GSK PIc, F. Hoffmann-La Roche Ltd, Novartis AG, AbbVie Inc

Based on molecule type, the pharmaceuticals market is segmented into small molecule, biological and biosimilar products. In 2024, the small molecule, segment held the largest share of the market. Based on indication, the pharmaceuticals market is segmented into metabolic diseases, cancer, immunology, respiratory disorder, cardiovascular disorder, neurology disorder, rare disease, others. In 2024, the cancer segment held the largest share of the market. Based on product, the pharmaceuticals market is segmented into branded, generic. In 2024, the branded segment held the largest share of the market. Based on distribution channel, the pharmaceuticals market is segmented into hospital pharmacies, retail pharmacies, online pharmacies. In 2024, the hospital pharmacies segment held the largest share of the market.

Various organic and inorganic strategies are adopted by companies operating in the Pharmaceuticals Market. The organic strategies mainly include product launches and product approvals. Inorganic growth strategies witnessed in the market are acquisitions, collaboration, and partnerships. These growth strategies allow the market players to expand their businesses and enhance their geographic presence, along with contributing to the overall market growth. Furthermore, strategies such as acquisitions and partnerships helped strengthen their customer base and extend their product portfolios. A few of the significant developments by key players in the Pharmaceuticals Market are listed below.

In March 2025, Janssen-Cilag International NV, a Johnson & Johnson company, announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) recommended approval for an expanded indication of DARZALEX (daratumumab) subcutaneous (SC) formulation. This recommendation is for its use in combination with bortezomib, lenalidomide, and dexamethasone (daratumumab-VRd) to treat adults with newly diagnosed multiple myeloma (NDMM).

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:

4. Pharmaceutical Market Landscape

4.1 Overview
4.2 PEST Analysis

5. Pharmaceutical Market - Key Market Dynamics

5.1 Pharmaceutical Market - Key Market Dynamics
5.2 Market Drivers
- 5.2.1 Rising Global Disease Burden and Increasing Demand for Innovative Treatments
- 5.2.2 Expanding Global Access to Medicines and Growing Emerging Markets
5.3 Market Restraints
- 5.3.1 Regulatory Pressures and Market Shifts
5.4 Market Opportunities
- 5.4.1 Harnessing Innovation, AI, and Market Expansion
5.5 Future Trends
- 5.5.1 Regional Power Shifts, Supply Chain Diversification, and Regulatory Evolution
5.6 Impact of Drivers and Restraints:

6. Pharmaceutical Market - Global Market Analysis

6.1 Pharmaceutical Market Revenue (US$ Billion), 2021-2031
6.2 Pharmaceutical Market Forecast Analysis

7. Pharmaceutical Market Analysis - by Molecule Type

7.1 Small Molecule
- 7.1.1 Overview
- 7.1.2 Small Molecule: Pharmaceutical Market - Revenue and Forecast to 2031 (US$ Billion)
7.2 Biological and Biosimilar Products
- 7.2.1 Overview
- 7.2.2 Biological and Biosimilar Products: Pharmaceutical Market - Revenue and Forecast to 2031 (US$ Billion)

8. Pharmaceutical Market Analysis - by Indication

8.1 Metabolic Diseases
- 8.1.1 Overview
- 8.1.2 Metabolic Diseases: Pharmaceutical Market - Revenue and Forecast to 2031 (US$ Billion)
8.2 Cancer
- 8.2.1 Overview
- 8.2.2 Cancer: Pharmaceutical Market - Revenue and Forecast to 2031 (US$ Billion)
8.3 Immunology
- 8.3.1 Overview
- 8.3.2 Immunology: Pharmaceutical Market - Revenue and Forecast to 2031 (US$ Billion)
8.4 Respiratory Disorder
- 8.4.1 Overview
- 8.4.2 Respiratory Disorder: Pharmaceutical Market - Revenue and Forecast to 2031 (US$ Billion)
8.5 Cardiovascular Disorder
- 8.5.1 Overview
- 8.5.2 Cardiovascular Disorder: Pharmaceutical Market - Revenue and Forecast to 2031 (US$ Billion)
8.6 Neurology Disorder
- 8.6.1 Overview
- 8.6.2 Neurology Disorder: Pharmaceutical Market - Revenue and Forecast to 2031 (US$ Billion)
8.7 Rare Disease
- 8.7.1 Overview
- 8.7.2 Rare Disease: Pharmaceutical Market - Revenue and Forecast to 2031 (US$ Billion)
8.8 Others
- 8.8.1 Overview
- 8.8.2 Others: Pharmaceutical Market - Revenue and Forecast to 2031 (US$ Billion)

9. Pharmaceutical Market Analysis - by Product

9.1 Branded
- 9.1.1 Overview
- 9.1.2 Branded: Pharmaceutical Market - Revenue and Forecast to 2031 (US$ Billion)
9.2 Generic
- 9.2.1 Overview
- 9.2.2 Generic: Pharmaceutical Market - Revenue and Forecast to 2031 (US$ Billion)

10. Pharmaceutical Market Analysis - by Type

10.1 Prescription
- 10.1.1 Overview
- 10.1.2 Prescription: Pharmaceutical Market - Revenue and Forecast to 2031 (US$ Billion)
10.2 OTC Drugs
- 10.2.1 Overview
- 10.2.2 OTC Drugs: Pharmaceutical Market - Revenue and Forecast to 2031 (US$ Billion)

11. Pharmaceutical Market Analysis - by Distribution Channel

11.1 Hospital Pharmacies
- 11.1.1 Overview
- 11.1.2 Hospital Pharmacies: Pharmaceutical Market - Revenue and Forecast to 2031 (US$ Billion)
11.2 Retail Pharmacies
- 11.2.1 Overview
- 11.2.2 Retail Pharmacies: Pharmaceutical Market - Revenue and Forecast to 2031 (US$ Billion)
11.3 Online Pharmacies
- 11.3.1 Overview
- 11.3.2 Online Pharmacies: Pharmaceutical Market - Revenue and Forecast to 2031 (US$ Billion)

12. Pharmaceutical Market - Geographical Analysis

12.1 Overview
12.2 North America
- 12.2.1 North America Pharmaceutical Market Overview
- 12.2.2 North America: Pharmaceutical Market - Revenue, 2021 - 2031 (US$ Billion)
- 12.2.3 North America: Pharmaceutical Market Breakdown, by Molecule Type
  - 12.2.3.1 North America: Pharmaceutical Market- Revenue and Forecast Analysis - by Molecule Type
- 12.2.4 North America: Pharmaceutical Market Breakdown, by Indication
  - 12.2.4.1 North America: Pharmaceutical Market- Revenue and Forecast Analysis - by Indication
- 12.2.5 North America: Pharmaceutical Market Breakdown, by Product
  - 12.2.5.1 North America: Pharmaceutical Market- Revenue and Forecast Analysis - by Product
- 12.2.6 North America: Pharmaceutical Market Breakdown, by Type
  - 12.2.6.1 North America: Pharmaceutical Market- Revenue and Forecast Analysis - by Type
- 12.2.7 North America: Pharmaceutical Market Breakdown, by Distribution Channel
  - 12.2.7.1 North America: Pharmaceutical Market- Revenue and Forecast Analysis - by Distribution Channel
- 12.2.8 North America: Pharmaceutical Market - Revenue and Forecast Analysis - by Country
  - 12.2.8.1 North America: Pharmaceutical Market - Revenue and Forecast Analysis - by Country
  - 12.2.8.2 United States: Pharmaceutical Market - Revenue, 2021 - 2031 (US$ Billion)
    - 12.2.8.2.1 United States: Pharmaceutical Market Breakdown, by Molecule Type
    - 12.2.8.2.2 United States: Pharmaceutical Market Breakdown, by Indication
    - 12.2.8.2.3 United States: Pharmaceutical Market Breakdown, by Product
    - 12.2.8.2.4 United States: Pharmaceutical Market Breakdown, by Type
    - 12.2.8.2.5 United States: Pharmaceutical Market Breakdown, by Distribution Channel
  - 12.2.8.3 Canada: Pharmaceutical Market - Revenue, 2021 - 2031 (US$ Billion)
    - 12.2.8.3.1 Canada: Pharmaceutical Market Breakdown, by Molecule Type
    - 12.2.8.3.2 Canada: Pharmaceutical Market Breakdown, by Indication
    - 12.2.8.3.3 Canada: Pharmaceutical Market Breakdown, by Product
    - 12.2.8.3.4 Canada: Pharmaceutical Market Breakdown, by Type
    - 12.2.8.3.5 Canada: Pharmaceutical Market Breakdown, by Distribution Channel
  - 12.2.8.4 Mexico: Pharmaceutical Market - Revenue, 2021 - 2031 (US$ Billion)
    - 12.2.8.4.1 Mexico: Pharmaceutical Market Breakdown, by Molecule Type
    - 12.2.8.4.2 Mexico: Pharmaceutical Market Breakdown, by Indication
    - 12.2.8.4.3 Mexico: Pharmaceutical Market Breakdown, by Product
    - 12.2.8.4.4 Mexico: Pharmaceutical Market Breakdown, by Type
    - 12.2.8.4.5 Mexico: Pharmaceutical Market Breakdown, by Distribution Channel
12.3 Europe
- 12.3.1 Europe Pharmaceutical Market Overview
- 12.3.2 Europe: Pharmaceutical Market - Revenue, 2021 - 2031 (US$ Billion)
- 12.3.3 Europe: Pharmaceutical Market Breakdown, by Molecule Type
  - 12.3.3.1 Europe: Pharmaceutical Market- Revenue and Forecast Analysis - by Molecule Type
- 12.3.4 Europe: Pharmaceutical Market Breakdown, by Indication
  - 12.3.4.1 Europe: Pharmaceutical Market- Revenue and Forecast Analysis - by Indication
- 12.3.5 Europe: Pharmaceutical Market Breakdown, by Product
  - 12.3.5.1 Europe: Pharmaceutical Market- Revenue and Forecast Analysis - by Product
- 12.3.6 Europe: Pharmaceutical Market Breakdown, by Type
  - 12.3.6.1 Europe: Pharmaceutical Market- Revenue and Forecast Analysis - by Type
- 12.3.7 Europe: Pharmaceutical Market Breakdown, by Distribution Channel
  - 12.3.7.1 Europe: Pharmaceutical Market- Revenue and Forecast Analysis - by Distribution Channel
- 12.3.8 Europe: Pharmaceutical Market - Revenue and Forecast Analysis - by Country
  - 12.3.8.1 Europe: Pharmaceutical Market - Revenue and Forecast Analysis - by Country
  - 12.3.8.2 United Kingdom: Pharmaceutical Market - Revenue, 2021 - 2031 (US$ Billion)
    - 12.3.8.2.1 United Kingdom: Pharmaceutical Market Breakdown, by Molecule Type
    - 12.3.8.2.2 United Kingdom: Pharmaceutical Market Breakdown, by Indication
    - 12.3.8.2.3 United Kingdom: Pharmaceutical Market Breakdown, by Product
    - 12.3.8.2.4 United Kingdom: Pharmaceutical Market Breakdown, by Type
    - 12.3.8.2.5 United Kingdom: Pharmaceutical Market Breakdown, by Distribution Channel
  - 12.3.8.3 Germany: Pharmaceutical Market - Revenue, 2021 - 2031 (US$ Billion)
    - 12.3.8.3.1 Germany: Pharmaceutical Market Breakdown, by Molecule Type
    - 12.3.8.3.2 Germany: Pharmaceutical Market Breakdown, by Indication
    - 12.3.8.3.3 Germany: Pharmaceutical Market Breakdown, by Product
    - 12.3.8.3.4 Germany: Pharmaceutical Market Breakdown, by Type
    - 12.3.8.3.5 Germany: Pharmaceutical Market Breakdown, by Distribution Channel
  - 12.3.8.4 France: Pharmaceutical Market - Revenue, 2021 - 2031 (US$ Billion)
    - 12.3.8.4.1 France: Pharmaceutical Market Breakdown, by Molecule Type
    - 12.3.8.4.2 France: Pharmaceutical Market Breakdown, by Indication
    - 12.3.8.4.3 France: Pharmaceutical Market Breakdown, by Product
    - 12.3.8.4.4 France: Pharmaceutical Market Breakdown, by Type
    - 12.3.8.4.5 France: Pharmaceutical Market Breakdown, by Distribution Channel
  - 12.3.8.5 Italy: Pharmaceutical Market - Revenue, 2021 - 2031 (US$ Billion)
    - 12.3.8.5.1 Italy: Pharmaceutical Market Breakdown, by Molecule Type
    - 12.3.8.5.2 Italy: Pharmaceutical Market Breakdown, by Indication
    - 12.3.8.5.3 Italy: Pharmaceutical Market Breakdown, by Product
    - 12.3.8.5.4 Italy: Pharmaceutical Market Breakdown, by Type
    - 12.3.8.5.5 Italy: Pharmaceutical Market Breakdown, by Distribution Channel
  - 12.3.8.6 Spain: Pharmaceutical Market - Revenue, 2021 - 2031 (US$ Billion)
    - 12.3.8.6.1 Spain: Pharmaceutical Market Breakdown, by Molecule Type
    - 12.3.8.6.2 Spain: Pharmaceutical Market Breakdown, by Indication
    - 12.3.8.6.3 Spain: Pharmaceutical Market Breakdown, by Product
    - 12.3.8.6.4 Spain: Pharmaceutical Market Breakdown, by Type
    - 12.3.8.6.5 Spain: Pharmaceutical Market Breakdown, by Distribution Channel
  - 12.3.8.7 Switzerland: Pharmaceutical Market - Revenue, 2021 - 2031 (US$ Billion)
    - 12.3.8.7.1 Switzerland: Pharmaceutical Market Breakdown, by Molecule Type
    - 12.3.8.7.2 Switzerland: Pharmaceutical Market Breakdown, by Indication
    - 12.3.8.7.3 Spain: Pharmaceutical Market Breakdown, by Product
    - 12.3.8.7.4 Spain: Pharmaceutical Market Breakdown, by Type
    - 12.3.8.7.5 Switzerland: Pharmaceutical Market Breakdown, by Distribution Channel
  - 12.3.8.8 Rest of Europe: Pharmaceutical Market - Revenue, 2021 - 2031 (US$ Billion)
    - 12.3.8.8.1 Rest of Europe: Pharmaceutical Market Breakdown, by Molecule Type
    - 12.3.8.8.2 Rest of Europe: Pharmaceutical Market Breakdown, by Indication
    - 12.3.8.8.3 Rest of Europe: Pharmaceutical Market Breakdown, by Product
    - 12.3.8.8.4 Rest of Europe: Pharmaceutical Market Breakdown, by Type
    - 12.3.8.8.5 Rest of Europe: Pharmaceutical Market Breakdown, by Distribution Channel
12.4 Asia Pacific
- 12.4.1 Asia Pacific Pharmaceutical Market Overview
- 12.4.2 Asia Pacific: Pharmaceutical Market - Revenue, 2021 - 2031 (US$ Billion)
- 12.4.3 Asia Pacific: Pharmaceutical Market Breakdown, by Molecule Type
  - 12.4.3.1 Asia Pacific: Pharmaceutical Market- Revenue and Forecast Analysis - by Molecule Type
- 12.4.4 Asia Pacific: Pharmaceutical Market Breakdown, by Indication
  - 12.4.4.1 Asia Pacific: Pharmaceutical Market- Revenue and Forecast Analysis - by Indication
- 12.4.5 Asia Pacific: Pharmaceutical Market Breakdown, by Product
  - 12.4.5.1 Asia Pacific: Pharmaceutical Market- Revenue and Forecast Analysis - by Product
- 12.4.6 Asia Pacific: Pharmaceutical Market Breakdown, by Type
  - 12.4.6.1 Asia Pacific: Pharmaceutical Market- Revenue and Forecast Analysis - by Type
- 12.4.7 Asia Pacific: Pharmaceutical Market Breakdown, by Distribution Channel
  - 12.4.7.1 Asia Pacific: Pharmaceutical Market- Revenue and Forecast Analysis - by Distribution Channel
- 12.4.8 Asia Pacific: Pharmaceutical Market - Revenue and Forecast Analysis - by Country
  - 12.4.8.1 Asia Pacific: Pharmaceutical Market - Revenue and Forecast Analysis - by Country
  - 12.4.8.2 China: Pharmaceutical Market - Revenue, 2021 - 2031 (US$ Billion)
    - 12.4.8.2.1 China: Pharmaceutical Market Breakdown, by Molecule Type
    - 12.4.8.2.2 China: Pharmaceutical Market Breakdown, by Indication
    - 12.4.8.2.3 China: Pharmaceutical Market Breakdown, by Product
    - 12.4.8.2.4 China: Pharmaceutical Market Breakdown, by Type
    - 12.4.8.2.5 China: Pharmaceutical Market Breakdown, by Distribution Channel
  - 12.4.8.3 Japan: Pharmaceutical Market - Revenue, 2021 - 2031 (US$ Billion)
    - 12.4.8.3.1 Japan: Pharmaceutical Market Breakdown, by Molecule Type
    - 12.4.8.3.2 Japan: Pharmaceutical Market Breakdown, by Indication
    - 12.4.8.3.3 Japan: Pharmaceutical Market Breakdown, by Product
    - 12.4.8.3.4 Japan: Pharmaceutical Market Breakdown, by Type
    - 12.4.8.3.5 Japan: Pharmaceutical Market Breakdown, by Distribution Channel
  - 12.4.8.4 India: Pharmaceutical Market - Revenue, 2021 - 2031 (US$ Billion)
    - 12.4.8.4.1 India: Pharmaceutical Market Breakdown, by Molecule Type
    - 12.4.8.4.2 India: Pharmaceutical Market Breakdown, by Indication
    - 12.4.8.4.3 India: Pharmaceutical Market Breakdown, by Product
    - 12.4.8.4.4 India: Pharmaceutical Market Breakdown, by Type
    - 12.4.8.4.5 India: Pharmaceutical Market Breakdown, by Distribution Channel
  - 12.4.8.5 Australia: Pharmaceutical Market - Revenue, 2021 - 2031 (US$ Billion)
    - 12.4.8.5.1 Australia: Pharmaceutical Market Breakdown, by Molecule Type
    - 12.4.8.5.2 Australia: Pharmaceutical Market Breakdown, by Indication
    - 12.4.8.5.3 Australia: Pharmaceutical Market Breakdown, by Product
    - 12.4.8.5.4 Australia: Pharmaceutical Market Breakdown, by Type
    - 12.4.8.5.5 Australia: Pharmaceutical Market Breakdown, by Distribution Channel
  - 12.4.8.6 South Korea: Pharmaceutical Market - Revenue, 2021 - 2031 (US$ Billion)
    - 12.4.8.6.1 South Korea: Pharmaceutical Market Breakdown, by Molecule Type
    - 12.4.8.6.2 South Korea: Pharmaceutical Market Breakdown, by Indication
    - 12.4.8.6.3 South Korea: Pharmaceutical Market Breakdown, by Product
    - 12.4.8.6.4 South Korea: Pharmaceutical Market Breakdown, by Type
    - 12.4.8.6.5 South Korea: Pharmaceutical Market Breakdown, by Distribution Channel
  - 12.4.8.7 Rest of APAC: Pharmaceutical Market - Revenue, 2021 - 2031 (US$ Billion)
    - 12.4.8.7.1 Rest of APAC: Pharmaceutical Market Breakdown, by Molecule Type
    - 12.4.8.7.2 Rest of APAC: Pharmaceutical Market Breakdown, by Indication
    - 12.4.8.7.3 Rest of APAC: Pharmaceutical Market Breakdown, by Product
    - 12.4.8.7.4 Rest of APAC: Pharmaceutical Market Breakdown, by Type
    - 12.4.8.7.5 Rest of APAC: Pharmaceutical Market Breakdown, by Distribution Channel
12.5 Middle East and Africa
- 12.5.1 Middle East and AfricaPharmaceutical Market Overview
- 12.5.2 Middle East and Africa: Pharmaceutical Market - Revenue, 2021 - 2031 (US$ Billion)
- 12.5.3 Middle East and Africa: Pharmaceutical Market Breakdown, by Molecule Type
  - 12.5.3.1 Middle East and Africa: Pharmaceutical Market- Revenue and Forecast Analysis - by Molecule Type
- 12.5.4 Middle East and Africa: Pharmaceutical Market Breakdown, by Indication
  - 12.5.4.1 Middle East and Africa: Pharmaceutical Market- Revenue and Forecast Analysis - by Indication
- 12.5.5 Middle East and Africa: Pharmaceutical Market Breakdown, by Product
  - 12.5.5.1 Middle East and Africa: Pharmaceutical Market- Revenue and Forecast Analysis - by Product
- 12.5.6 Middle East and Africa: Pharmaceutical Market Breakdown, by Type
  - 12.5.6.1 Middle East and Africa: Pharmaceutical Market- Revenue and Forecast Analysis - by Type
- 12.5.7 Middle East and Africa: Pharmaceutical Market Breakdown, by Distribution Channel
  - 12.5.7.1 Middle East and Africa: Pharmaceutical Market- Revenue and Forecast Analysis - by Distribution Channel
- 12.5.8 Middle East and Africa: Pharmaceutical Market - Revenue and Forecast Analysis - by Country
  - 12.5.8.1 Middle East and Africa: Pharmaceutical Market - Revenue and Forecast Analysis - by Country
  - 12.5.8.2 South Africa: Pharmaceutical Market - Revenue, 2021 - 2031 (US$ Billion)
    - 12.5.8.2.1 South Africa: Pharmaceutical Market Breakdown, by Molecule Type
    - 12.5.8.2.2 South Africa: Pharmaceutical Market Breakdown, by Indication
    - 12.5.8.2.3 South Africa: Pharmaceutical Market Breakdown, by Product
    - 12.5.8.2.4 South Africa: Pharmaceutical Market Breakdown, by Type
    - 12.5.8.2.5 South Africa: Pharmaceutical Market Breakdown, by Distribution Channel
  - 12.5.8.3 Saudi Arabia: Pharmaceutical Market - Revenue, 2021 - 2031 (US$ Billion)
    - 12.5.8.3.1 Saudi Arabia: Pharmaceutical Market Breakdown, by Molecule Type
    - 12.5.8.3.2 Saudi Arabia: Pharmaceutical Market Breakdown, by Indication
    - 12.5.8.3.3 Saudi Arabia: Pharmaceutical Market Breakdown, by Product
    - 12.5.8.3.4 Saudi Arabia: Pharmaceutical Market Breakdown, by Type
    - 12.5.8.3.5 Saudi Arabia: Pharmaceutical Market Breakdown, by Distribution Channel
  - 12.5.8.4 United Arab Emirates: Pharmaceutical Market - Revenue, 2021 - 2031 (US$ Billion)
    - 12.5.8.4.1 United Arab Emirates: Pharmaceutical Market Breakdown, by Molecule Type
    - 12.5.8.4.2 United Arab Emirates: Pharmaceutical Market Breakdown, by Indication
    - 12.5.8.4.3 United Arab Emirates: Pharmaceutical Market Breakdown, by Product
    - 12.5.8.4.4 United Arab Emirates: Pharmaceutical Market Breakdown, by Type
    - 12.5.8.4.5 United Arab Emirates: Pharmaceutical Market Breakdown, by Distribution Channel
  - 12.5.8.5 Rest of Middle East and Africa: Pharmaceutical Market - Revenue, 2021 - 2031 (US$ Billion)
    - 12.5.8.5.1 Rest of Middle East and Africa: Pharmaceutical Market Breakdown, by Molecule Type
    - 12.5.8.5.2 Rest of Middle East and Africa: Pharmaceutical Market Breakdown, by Indication
    - 12.5.8.5.3 Rest of Middle East and Africa: Pharmaceutical Market Breakdown, by Product
    - 12.5.8.5.4 Rest of Middle East and Africa: Pharmaceutical Market Breakdown, by Type
    - 12.5.8.5.5 Rest of Middle East and Africa: Pharmaceutical Market Breakdown, by Distribution Channel
12.6 South and Central America
- 12.6.1 South and Central AmericaPharmaceutical Market Overview
- 12.6.2 South and Central America: Pharmaceutical Market - Revenue, 2021 - 2031 (US$ Billion)
- 12.6.3 South and Central America: Pharmaceutical Market Breakdown, by Molecule Type
  - 12.6.3.1 South and Central America: Pharmaceutical Market- Revenue and Forecast Analysis - by Molecule Type
- 12.6.4 South and Central America: Pharmaceutical Market Breakdown, by Indication
  - 12.6.4.1 South and Central America: Pharmaceutical Market- Revenue and Forecast Analysis - by Indication
- 12.6.5 South and Central America: Pharmaceutical Market Breakdown, by Product
  - 12.6.5.1 South and Central America: Pharmaceutical Market- Revenue and Forecast Analysis - by Product
- 12.6.6 South and Central America: Pharmaceutical Market Breakdown, by Type
  - 12.6.6.1 South and Central America: Pharmaceutical Market- Revenue and Forecast Analysis - by Type
- 12.6.7 South and Central America: Pharmaceutical Market Breakdown, by Distribution Channel
  - 12.6.7.1 South and Central America: Pharmaceutical Market- Revenue and Forecast Analysis - by Distribution Channel
- 12.6.8 South and Central America: Pharmaceutical Market - Revenue and Forecast Analysis - by Country
  - 12.6.8.1 South and Central America: Pharmaceutical Market - Revenue and Forecast Analysis - by Country
  - 12.6.8.2 Brazil: Pharmaceutical Market - Revenue, 2021 - 2031 (US$ Billion)
    - 12.6.8.2.1 Brazil: Pharmaceutical Market Breakdown, by Molecule Type
    - 12.6.8.2.2 Brazil: Pharmaceutical Market Breakdown, by Indication
    - 12.6.8.2.3 Brazil: Pharmaceutical Market Breakdown, by Product
    - 12.6.8.2.4 Brazil: Pharmaceutical Market Breakdown, by Type
    - 12.6.8.2.5 Brazil: Pharmaceutical Market Breakdown, by Distribution Channel
  - 12.6.8.3 Argentina: Pharmaceutical Market - Revenue, 2021 - 2031 (US$ Billion)
    - 12.6.8.3.1 Argentina: Pharmaceutical Market Breakdown, by Molecule Type
    - 12.6.8.3.2 Argentina: Pharmaceutical Market Breakdown, by Indication
    - 12.6.8.3.3 Argentina: Pharmaceutical Market Breakdown, by Product
    - 12.6.8.3.4 Argentina: Pharmaceutical Market Breakdown, by Type
    - 12.6.8.3.5 Argentina: Pharmaceutical Market Breakdown, by Distribution Channel
  - 12.6.8.4 Rest of South and Central America: Pharmaceutical Market - Revenue, 2021 - 2031 (US$ Billion)
    - 12.6.8.4.1 Rest of South and Central America: Pharmaceutical Market Breakdown, by Molecule Type
    - 12.6.8.4.2 Rest of South and Central America: Pharmaceutical Market Breakdown, by Indication
    - 12.6.8.4.3 Rest of South and Central America: Pharmaceutical Market Breakdown, by Product
    - 12.6.8.4.4 Rest of South and Central America: Pharmaceutical Market Breakdown, by Type
    - 12.6.8.4.5 Rest of South and Central America: Pharmaceutical Market Breakdown, by Distribution Channel

13. Competitive Landscape

13.1 Company Market Share Analysis

14. Industry Landscape

14.1 Overview
14.2 Expansion
14.3 New Product Development
14.4 Merger and Acquisition
14.5 Partnerships
14.6 Other Business Strategies

15. Company Profiles

15.1 Johnson & Johnson
- 15.1.1 Key Facts
- 15.1.2 Business Description
- 15.1.3 Products and Services
- 15.1.4 Financial Overview
- 15.1.5 SWOT Analysis
- 15.1.6 Key Developments
15.2 Pfizer Inc
- 15.2.1 Key Facts
- 15.2.2 Business Description
- 15.2.3 Products and Services
- 15.2.4 Financial Overview
- 15.2.5 SWOT Analysis
- 15.2.6 Key Developments
15.3 Merck & Co Inc
- 15.3.1 Key Facts
- 15.3.2 Business Description
- 15.3.3 Products and Services
- 15.3.4 Financial Overview
- 15.3.5 SWOT Analysis
- 15.3.6 Key Developments
15.4 Eli Lilly and Co
- 15.4.1 Key Facts
- 15.4.2 Business Description
- 15.4.3 Financial Overview
- 15.4.4 SWOT Analysis
- 15.4.5 Key Developments
15.5 Bristol-Myers Squibb Co
- 15.5.1 Key Facts
- 15.5.2 Business Description
- 15.5.3 Products and Services
- 15.5.4 Financial Overview
- 15.5.5 SWOT Analysis
- 15.5.6 Key Developments
15.6 ESTEVE
- 15.6.1 Key Facts
- 15.6.2 Business Description
- 15.6.3 Products and Services
- 15.6.4 Financial Overview
- 15.6.5 SWOT Analysis
- 15.6.6 Key Developments
15.7 UCB SA
- 15.7.1 Key Facts
- 15.7.2 Business Description
- 15.7.3 Products and Services
- 15.7.4 Financial Overview
- 15.7.5 SWOT Analysis
- 15.7.6 Key Developments
15.8 Teva Pharmaceutical Industries Ltd
- 15.8.1 Key Facts
- 15.8.2 Business Description
- 15.8.3 Products and Services
- 15.8.4 Financial Overview
- 15.8.5 SWOT Analysis
- 15.8.6 Key Developments
15.9 Hikma Pharmaceuticals Plc
- 15.9.1 Key Facts
- 15.9.2 Business Description
- 15.9.3 Products and Services
- 15.9.4 Financial Overview
- 15.9.5 SWOT Analysis
- 15.9.6 Key Developments
15.10 Viatris Inc
- 15.10.1 Key Facts
- 15.10.2 Business Description
- 15.10.3 Products and Services
- 15.10.4 Financial Overview
- 15.10.5 SWOT Analysis
- 15.10.6 Key Developments
15.11 AstraZeneca Plc
- 15.11.1 1Key Facts
- 15.11.2 Business Description
- 15.11.3 Products and Services
- 15.11.4 Financial Overview
- 15.11.5 SWOT Analysis
- 15.11.6 Key Developments
15.12 Sanofi SA
- 15.12.1 Key Facts
- 15.12.2 Business Description
- 15.12.3 Products and Services
- 15.12.4 Financial Overview
- 15.12.5 SWOT Analysis
- 15.12.6 Key Developments
15.13 GSK Plc
- 15.13.1 Key Facts
- 15.13.2 Business Description
- 15.13.3 Products and Services
- 15.13.4 Financial Overview
- 15.13.5 SWOT Analysis
- 15.13.6 Key Developments
15.14 F. Hoffmann-La Roche Ltd
- 15.14.1 Key Facts
- 15.14.2 Business Description
- 15.14.3 Products and Services
- 15.14.4 Financial Overview
- 15.14.5 SWOT Analysis
- 15.14.6 Key Developments
15.15 Novartis AG
- 15.15.1 Key Facts
- 15.15.2 Business Description
- 15.15.3 Products and Services
- 15.15.4 Financial Overview
- 15.15.5 SWOT Analysis
- 15.15.6 Key Developments
15.16 AbbVie Inc
- 15.16.1 Key Facts
- 15.16.2 Business Description
- 15.16.3 Products and Services
- 15.16.4 Financial Overview
- 15.16.5 SWOT Analysis
- 15.16.6 Key Developments

16. Appendix

16.1 Glossary of Terms
16.2 About The Insight Partners

医薬品：市場規模と予測 (2021～2031年)、世界・地域シェア、動向、成長機会 - 分析範囲 (分子の種類別、適応症別、製品別、種類別、流通チャネル別、地域別)

Pharmaceuticals Market Size and Forecast 2021 - 2031, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Molecule Type, Indication, Product, Type, Distribution Channel, and Geography

目次

第1章イントロダクション

第2章エグゼクティブサマリー

第3章分析手法

第4章医薬品市場の情勢

第5章医薬品市場：主な市場力学

第6章医薬品市場：世界市場の分析

第7章医薬品市場の分析：分子の種類別

第8章医薬品市場の分析：適応症別

第9章医薬品市場の分析：製品別

第10章医薬品市場の分析：種類別

第11章医薬品市場の分析：流通チャネル別

第12章医薬品市場：地域別分析

第13章競合情勢

第14章業界情勢

第15章企業プロファイル

第16章付録

List Of Tables

List Of Figures

Table Of Contents

1. Introduction

2. Executive Summary

3. Research Methodology

4. Pharmaceutical Market Landscape

5. Pharmaceutical Market - Key Market Dynamics

6. Pharmaceutical Market - Global Market Analysis

7. Pharmaceutical Market Analysis - by Molecule Type

8. Pharmaceutical Market Analysis - by Indication

9. Pharmaceutical Market Analysis - by Product

10. Pharmaceutical Market Analysis - by Type

11. Pharmaceutical Market Analysis - by Distribution Channel

12. Pharmaceutical Market - Geographical Analysis

13. Competitive Landscape

14. Industry Landscape

15. Company Profiles

16. Appendix

医薬品：市場規模と予測 (2021～2031年)、世界・地域シェア、動向、成長機会 - 分析範囲 (分子の種類別、適応症別、製品別、種類別、流通チャネル別、地域別)

Pharmaceuticals Market Size and Forecast 2021 - 2031, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Molecule Type, Indication, Product, Type, Distribution Channel, and Geography

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 分析手法

第4章 医薬品市場の情勢

第5章 医薬品市場：主な市場力学

第6章 医薬品市場：世界市場の分析

第7章 医薬品市場の分析：分子の種類別

第8章 医薬品市場の分析：適応症別

第9章 医薬品市場の分析：製品別

第10章 医薬品市場の分析：種類別

第11章 医薬品市場の分析：流通チャネル別

第12章 医薬品市場：地域別分析

第13章 競合情勢

第14章 業界情勢

第15章 企業プロファイル

第16章 付録

List Of Tables

List Of Figures

Table Of Contents

1. Introduction

2. Executive Summary

3. Research Methodology

4. Pharmaceutical Market Landscape

5. Pharmaceutical Market - Key Market Dynamics

6. Pharmaceutical Market - Global Market Analysis

7. Pharmaceutical Market Analysis - by Molecule Type

8. Pharmaceutical Market Analysis - by Indication

9. Pharmaceutical Market Analysis - by Product

10. Pharmaceutical Market Analysis - by Type

11. Pharmaceutical Market Analysis - by Distribution Channel

12. Pharmaceutical Market - Geographical Analysis

13. Competitive Landscape

14. Industry Landscape

15. Company Profiles

16. Appendix

第1章イントロダクション

第2章エグゼクティブサマリー

第3章分析手法

第4章医薬品市場の情勢

第5章医薬品市場：主な市場力学

第6章医薬品市場：世界市場の分析

第7章医薬品市場の分析：分子の種類別

第8章医薬品市場の分析：適応症別

第9章医薬品市場の分析：製品別

第10章医薬品市場の分析：種類別

第11章医薬品市場の分析：流通チャネル別

第12章医薬品市場：地域別分析

第13章競合情勢

第14章業界情勢

第15章企業プロファイル

第16章付録